We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biosynex SA (ALBIO) EUR0.10

Sell:€3.70 Buy:€3.88 Change: €0.22 (6.03%)
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:€3.70
Buy:€3.88
Change: €0.22 (6.03%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:€3.70
Buy:€3.88
Change: €0.22 (6.03%)
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.

Contact details

Address:
22 Boulevard Sebastien Brant
ILLKIRCH-GRAFFENSTADEN
67400
France
Telephone:
+33 (3) 88787887
Website:
https://www.biosynex.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALBIO
ISIN:
FR0011005933
Market cap:
€37.53 million
Shares in issue:
10.44 million
Sector:
Health Care Equipment
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Larry Abensur
    Chief Executive Officer, Director
  • Thomas Lamy
    Deputy Chief Executive Officer, Director
  • Thierry Paper
    Deputy Chief Executive Officer - Research and Business development, Administrator

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.